ID24264A - COMPOSITION CONSIST OF 5- [4- [2- (N-METHYL-N-2-PYRIDYL) AMINO) ETHOCYSIE [BENZIL] TIAZOLIDIN-2,4-DION - Google Patents

COMPOSITION CONSIST OF 5- [4- [2- (N-METHYL-N-2-PYRIDYL) AMINO) ETHOCYSIE [BENZIL] TIAZOLIDIN-2,4-DION

Info

Publication number: ID24264A
Authority: ID; Indonesia
Prior art keywords: ethocysie; tiazolidin; dion; benzil; pyridyl
Prior art date: 1997-06-05

Application number

IDW991520A

Other languages

Indonesian (id)

Inventor

Jeffrey Roger Granett

Original Assignee

Smithkline Beecham P L C Cs

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-06-05

Filing date

1998-06-02

Publication date

2000-07-13

1997-06-18 Priority claimed from GBGB9712851.6A external-priority patent/GB9712851D0/en

1998-06-02 Application filed by Smithkline Beecham P L C Cs filed Critical Smithkline Beecham P L C Cs

2000-07-13 Publication of ID24264A publication Critical patent/ID24264A/en

Links

-1 AMINO Chemical class 0.000 title 1
229920004518 DION® Polymers 0.000 title 1
WURBFLDFSFBTLW-UHFFFAOYSA-N benzil Chemical compound C=1C=CC=CC=1C(=O)C(=O)C1=CC=CC=C1 WURBFLDFSFBTLW-UHFFFAOYSA-N 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

Health & Medical Sciences (AREA)
Diabetes (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Hematology (AREA)
Obesity (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Epidemiology (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicinal Preparation (AREA)

IDW991520A 1997-06-05 1998-06-02 COMPOSITION CONSIST OF 5- [4- [2- (N-METHYL-N-2-PYRIDYL) AMINO) ETHOCYSIE [BENZIL] TIAZOLIDIN-2,4-DION ID24264A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB9711683.4A GB9711683D0 (en)	1997-06-05	1997-06-05	Composition
GBGB9712851.6A GB9712851D0 (en)	1997-06-18	1997-06-18	Composition
PCT/EP1998/003478 WO1998055122A1 (en)	1997-06-05	1998-06-02	Composition comprising 5-[4-[2-(n-methyl-n-2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione

Publications (1)

Publication Number	Publication Date
ID24264A true ID24264A (en)	2000-07-13

Family

ID=26311662

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IDW991520A ID24264A (en)	1997-06-05	1998-06-02	COMPOSITION CONSIST OF 5- [4- [2- (N-METHYL-N-2-PYRIDYL) AMINO) ETHOCYSIE [BENZIL] TIAZOLIDIN-2,4-DION

Country Status (29)

Country	Link
EP (1)	EP0998284A1 (en)
JP (1)	JP2001521553A (en)
KR (1)	KR20010013410A (en)
CN (3)	CN1112926C (en)
AP (1)	AP1214A (en)
AR (2)	AR008198A1 (en)
AU (1)	AU8215098A (en)
BG (1)	BG104048A (en)
BR (1)	BR9810405A (en)
CA (2)	CA2292629C (en)
CO (1)	CO4940400A1 (en)
DZ (1)	DZ2510A1 (en)
EA (1)	EA002384B1 (en)
GB (1)	GB9711683D0 (en)
HU (1)	HUP0004070A3 (en)
ID (1)	ID24264A (en)
IL (1)	IL133074A0 (en)
MX (1)	MXPA99011322A (en)
NO (2)	NO995938L (en)
NZ (2)	NZ523725A (en)
OA (1)	OA11306A (en)
PE (1)	PE78899A1 (en)
PL (1)	PL337201A1 (en)
SK (1)	SK164899A3 (en)
TR (2)	TR200002790T2 (en)
TW (1)	TW570797B (en)
UY (1)	UY25032A1 (en)
WO (1)	WO1998055122A1 (en)
ZA (2)	ZA9811572B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7045519B2 (en)	1998-06-19	2006-05-16	Chiron Corporation	Inhibitors of glycogen synthase kinase 3
UA67844C2 (en) *	1999-04-23	2004-07-15	Смітклайн Бічам Плс	A polymorph of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl] thiazolidine-2,4-dione of maleic acid salt
US20040248945A1 (en)	1999-04-23	2004-12-09	Smithkline Beecham P.L.C.	Thiazolidinedione derivative and its use as antidiabetic
DE60004658T2 (en)	1999-04-23	2004-06-24	Smithkline Beecham Plc, Brentford	THIAZOLIDINDEDE DERIVATIVE AND ITS USE AS ANTIDIBLE
GB0021978D0 (en)	2000-09-07	2000-10-25	Smithkline Beecham Plc	Novel pharmaceutical
GB0127805D0 (en) *	2001-11-20	2002-01-09	Smithkline Beecham Plc	Pharmaceutical composition
GB0129876D0 (en) *	2001-12-13	2002-02-06	Smithkline Beecham Plc	Novel pharmaceutical
GB0129871D0 (en) *	2001-12-13	2002-02-06	Smithkline Beecham Plc	Novel pharmaceutical
WO2003050112A1 (en) *	2001-12-13	2003-06-19	Smithkline Beecham Plc	Toluenesulfonate hydrates of a thiazolidinedione derivative
GB0130509D0 (en) *	2001-12-20	2002-02-06	Smithkline Beecham Plc	Novel pharmaceutical
DE06252444T8 (en) *	2006-05-09	2009-03-19	Teva Pharmaceutical Industries Ltd.	2-N- {5 - [[4- [2- (Methyl-2-pyridinylamino) -ethoxy] -phenyl] -methyl] -2,4-thiazolidinedione-succinic acid, method of preparation and compositions with rosiglitazone maleate
US7435741B2 (en)	2006-05-09	2008-10-14	Teva Pharmaceutical Industries, Ltd.	2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
WO2015008234A1 (en) *	2013-07-17	2015-01-22	Glenmark Pharmaceuticals S.A.	Bicyclic heterocyclic compounds as ror gamma modulators

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SG59988A1 (en) *	1987-09-04	1999-02-22	Beecham Group Plc	Substituted thiazolidinedione derivatives
GB9218830D0 (en) *	1992-09-05	1992-10-21	Smithkline Beecham Plc	Novel compounds
MX9603338A (en) *	1994-02-10	1997-03-29	Smithkline Beecham Plc	Use of insulin sensitisers for treating renal diseases.
JPH11510508A (en) *	1995-08-10	1999-09-14	ワーナー−ランバート・コンパニー	Methods for reducing the amount of exogenous insulin administered to non-insulin dependent diabetes mellitus patients
WO1997018811A1 (en) *	1995-11-17	1997-05-29	Warner-Lambert Company	A method of treating myotonic dystrophy
NZ314406A (en) *	1996-03-18	2000-12-22	Sankyo Co	Treatment or prophylaxis of pancreatitis with a medicament containing an insulin sensitiser including oxazoles and thiazoles
EP0921798A1 (en) *	1996-07-12	1999-06-16	Smithkline Beecham Plc	Novel treatment of leptine resistance

1997
- 1997-06-05 GB GBGB9711683.4A patent/GB9711683D0/en active Pending
1998
- 1998-06-02 HU HU0004070A patent/HUP0004070A3/en unknown
- 1998-06-02 PL PL98337201A patent/PL337201A1/en unknown
- 1998-06-02 CA CA002292629A patent/CA2292629C/en not_active Expired - Fee Related
- 1998-06-02 ID IDW991520A patent/ID24264A/en unknown
- 1998-06-02 EP EP98932144A patent/EP0998284A1/en not_active Withdrawn
- 1998-06-02 EA EA199901116A patent/EA002384B1/en not_active IP Right Cessation
- 1998-06-02 TR TR2000/02790T patent/TR200002790T2/en unknown
- 1998-06-02 CA CA002333352A patent/CA2333352A1/en not_active Abandoned
- 1998-06-02 JP JP50158799A patent/JP2001521553A/en not_active Ceased
- 1998-06-02 NZ NZ523725A patent/NZ523725A/en unknown
- 1998-06-02 AP APAP/P/1999/001696A patent/AP1214A/en active
- 1998-06-02 AU AU82150/98A patent/AU8215098A/en not_active Abandoned
- 1998-06-02 IL IL13307498A patent/IL133074A0/en unknown
- 1998-06-02 MX MXPA99011322A patent/MXPA99011322A/en unknown
- 1998-06-02 CN CN98805686A patent/CN1112926C/en not_active Expired - Lifetime
- 1998-06-02 WO PCT/EP1998/003478 patent/WO1998055122A1/en not_active Ceased
- 1998-06-02 TR TR1999/02963T patent/TR199902963T2/en unknown
- 1998-06-02 BR BR9810405-5A patent/BR9810405A/en not_active IP Right Cessation
- 1998-06-02 SK SK1648-99A patent/SK164899A3/en unknown
- 1998-06-02 KR KR19997011411A patent/KR20010013410A/en not_active Ceased
- 1998-06-02 CN CNA2003101199090A patent/CN1526391A/en active Pending
- 1998-06-03 DZ DZ980120A patent/DZ2510A1/en active
- 1998-06-04 UY UY25032A patent/UY25032A1/en not_active IP Right Cessation
- 1998-06-04 CO CO98031614A patent/CO4940400A1/en unknown
- 1998-06-04 ZA ZA9811572A patent/ZA9811572B/en unknown
- 1998-06-04 AR ARP980102649A patent/AR008198A1/en not_active Application Discontinuation
- 1998-06-04 AR ARP980102650A patent/AR015120A1/en not_active Application Discontinuation
- 1998-06-04 ZA ZA9804826A patent/ZA984826B/en unknown
- 1998-06-05 PE PE1998000466A patent/PE78899A1/en not_active Application Discontinuation
- 1998-10-23 TW TW087117536A patent/TW570797B/en not_active IP Right Cessation
1999
- 1999-12-02 OA OA9900267A patent/OA11306A/en unknown
- 1999-12-03 NO NO995938A patent/NO995938L/en not_active Application Discontinuation
- 1999-12-27 BG BG104048A patent/BG104048A/en unknown
2001
- 2001-09-03 NZ NZ513922A patent/NZ513922A/en unknown
2002
- 2002-11-05 CN CN02149972A patent/CN1430959A/en active Pending
2004
- 2004-02-20 NO NO20040738A patent/NO20040738L/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
AP9901696A0 (en)	1999-12-31
EP0998284A1 (en)	2000-05-10
AU8215098A (en)	1998-12-21
BR9810405A (en)	2000-08-29
SK164899A3 (en)	2000-11-07
KR20010013410A (en)	2001-02-26
NZ513922A (en)	2001-09-28
CN1112926C (en)	2003-07-02
CA2292629C (en)	2004-01-06
TR199902963T2 (en)	2000-02-21
TW570797B (en)	2004-01-11
CN1259050A (en)	2000-07-05
TR200002790T2 (en)	2001-11-21
CA2292629A1 (en)	1998-12-10
DZ2510A1 (en)	2003-01-25
WO1998055122A1 (en)	1998-12-10
CN1526391A (en)	2004-09-08
BG104048A (en)	2000-07-31
NO995938L (en)	2000-02-02
AR015120A1 (en)	2001-04-18
ZA984826B (en)	1999-08-03
EA199901116A1 (en)	2000-06-26
AR008198A1 (en)	1999-12-29
IL133074A0 (en)	2001-03-19
CO4940400A1 (en)	2000-07-24
NO995938D0 (en)	1999-12-03
HUP0004070A3 (en)	2002-03-28
HUP0004070A2 (en)	2002-02-28
PE78899A1 (en)	1999-10-22
NO20040738L (en)	2000-02-02
JP2001521553A (en)	2001-11-06
GB9711683D0 (en)	1997-08-06
ZA9811572B (en)	1999-07-22
CN1430959A (en)	2003-07-23
AP1214A (en)	2003-10-08
CA2333352A1 (en)	1998-12-10
OA11306A (en)	2003-10-22
PL337201A1 (en)	2000-08-14
NZ523725A (en)	2004-09-24
UY25032A1 (en)	1998-11-26
MXPA99011322A (en)	2004-12-02
EA002384B1 (en)	2002-04-25

Publication	Publication Date	Title
ATE231132T1 (en)	2003-02-15	HETEROCYCLIC METALLOPROTEASE INHIBITORS
DK0923561T3 (en)	2003-02-24	Heterocyclic metalloprotease inhibitors
ATE267805T1 (en)	2004-06-15	LACTAM COMPOUNDS AS METALLOPROTEASE INHIBITORS
ATE443055T1 (en)	2009-10-15	TYPE 1 11-BETA-HYDROXY-STEROID DEHYDROGENASE INHIBITORS
DE69940115D1 (en)	2009-01-29	HETEROCYCLIC INHIBITORS OF P38
NO20021116D0 (en)	2002-03-06	New composition
DE69830410D1 (en)	2005-07-07	META BENZAMIDINE DERIVATIVES AS SERINE PROTEASE INHIBITORS
DK1114051T3 (en)	2003-07-14	Inhibitors of p38
MA26500A1 (en)	2004-12-20	NEW FORM OF S-OMERPRAZOLE
EE200200132A (en)	2003-12-15	Novel spiroheterocyclic compounds useful as reversible inhibitors of cysteine proteases
ID24264A (en)	2000-07-13	COMPOSITION CONSIST OF 5- [4- [2- (N-METHYL-N-2-PYRIDYL) AMINO) ETHOCYSIE [BENZIL] TIAZOLIDIN-2,4-DION
NO990548L (en)	1999-04-07	Inhibitors of cysteine protease
MA26812A1 (en)	2004-12-20	PYRIMIDINE-2,4,6-TRIONES INHIBITORS OF METALLOPROTEINASES
NO20020307D0 (en)	2002-01-21	N- (indolecarbonyl) piperazine
EP1221482A4 (en)	2003-03-26	NEW HEMOPOIETINE RECEPTOR PROTEIN (NR12)
NO20021115L (en)	2002-04-30	New composition
DE60009675D1 (en)	2004-05-13	COMPOSITION CONTAINING PROTON PUMP INHIBITORS
ATE259590T1 (en)	2004-03-15	POUR-ON FORMULATIONS
ATE333866T1 (en)	2006-08-15	DISPERSION FORMULATIONS CONTAINING LIPASE INHIBITORS
ID30226A (en)	2001-11-15	COMPOSITION OF HAIR PENAT
DK0928291T3 (en)	2003-03-17	3-Mercaptoacetylamino-1,5-substituted 2-oxo-azepane derivatives useful as inhibitors of matrix metalloproteinase
ID24267A (en)	2000-07-13	ENANSIOMERS OF 4 - [[(SIANOIMINO) [(1,2,2-TRIMETHYLOPOPIL) AMINO] METHYL] AMINO] BENZONITRIL
DK199901730A (en)	2000-12-23	New Composition
DK0928192T3 (en)	2002-08-19	High-release active substance antimycotic gel
BR9710322A (en)	1999-08-17	Substituted N- (5-isothiazolyl) thioamides